Cubist Systematic Strategies’s Spyre Therapeutics SYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-49,303
| Closed | -$1.87M | – | 2532 |
|
|
2024
Q1 | $1.87M | Buy |
49,303
+23,153
| +89% | +$878K | 0.01% | 895 |
|
|
2023
Q4 | $563K | Buy |
+26,150
| New | +$563K | ﹤0.01% | 1333 |
|
|
2022
Q2 | – | Sell |
-484
| Closed | -$28K | – | 4026 |
|
|
2022
Q1 | $28K | Sell |
484
-1,754
| -78% | -$101K | ﹤0.01% | 3426 |
|
|
2021
Q4 | $266K | Buy |
+2,238
| New | +$266K | ﹤0.01% | 2883 |
|
|
2021
Q3 | – | Sell |
-469
| Closed | -$82K | – | 3167 |
|
|
2021
Q2 | $82K | Sell |
469
-244
| -34% | -$42.7K | ﹤0.01% | 2737 |
|
|
2021
Q1 | $141K | Buy |
713
+345
| +94% | +$68.2K | ﹤0.01% | 2575 |
|
|
2020
Q4 | $72K | Buy |
368
+12
| +3% | +$2.35K | ﹤0.01% | 2437 |
|
|
2020
Q3 | $63K | Sell |
356
-70
| -16% | -$12.4K | ﹤0.01% | 2346 |
|
|
2020
Q2 | $98K | Buy |
+426
| New | +$98K | ﹤0.01% | 2197 |
|
|
2018
Q3 | – | Sell |
-494
| Closed | -$131K | – | 2055 |
|
|
2018
Q2 | $131K | Buy |
+494
| New | +$131K | 0.01% | 1463 |
|